RSS   Newsletter   Contact   Advertise with us
Post Online Media

Bellerophon Therapeutics promotes Fabian Tenenbaum to CEO

Bellerophon TherapeuticsBellerophon Therapeutics announced the transition of Fabian Tenenbaum, current chief financial officer and chief business officer, to chief executive officer.
Article continues below

READ MORE Bellerophon Therapeutics appoints Mary Ann Cloyd as director

Mr. Tenenbaum serves as Company's Chief Financial Officer and Chief Business Officer. He served as Chief Financial Officer and Chief Business Officer of Anterios, Inc., a clinical-stage biopharmaceutical company, from 2014 to 2016.

Prior to that, Mr. Tenenbaum served as Chief Executive Officer with Syneron Beauty from 2011 to 2014, and Chief Financial Officer and Executive Vice President of Syneron Medical from 2007 to 2011.

Prior to Syneron Medical, Mr. Tenenbaum was Vice President Americas for Radiancy, Inc., from 2002 to 2006, and Director, Commercial Operations and Corporate Development at Sunlight Medical, Inc. from 1999 to 2002.

Mr. Tenenbaum holds a Bachelor in Medicine (B.Md.) from Ben Gurion University, Israel and an MBA from Columbia Business School.



We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy